Novelis (NVL) Stock Analysis
NYSEBasic MaterialsAluminum
What Novelis does
Novelis Inc. stands out as a premier provider of sustainable aluminum solutions, notably holding the title of the world's largest aluminum recycler. It manufactures advanced aluminum products characterized by innovation, a low carbon footprint, and substantial recycled content. These materials cater to a wide array of sectors, including automotive, aerospace, beverage packaging, and various specialized applications. Boasting an integrated network of technologically advanced rolling and recycling facilities located across North and South America, Europe, and Asia, Novelis effectively utilizes its vast global reach to supply high-quality, low-carbon aluminum products across the globe.
Key metrics
ETFs linked to NVL
Broad-market and Basic Materials sector ETFs an investor holding Novelis is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NVL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NVL in PortView →Frequently asked questions
- What is the ticker symbol for Novelis?
- Novelis trades under the ticker NVL on NYSE.
- Which exchange is NVL listed on?
- NVL is listed on NYSE.
- What sector does Novelis operate in?
- Novelis is classified in the Basic Materials sector (Aluminum industry).
- How can PortView help analyze NVL in a portfolio?
- PortView shows NVL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.